NCT00847795View on ClinicalTrials.gov

Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions
Cicatrix
Interventions
DRUG

Avotermin

Intradermal administration

DRUG

Placebo

Placebo

Trial Locations (1)

M13 9XX

Renovo CTU, Manchester

All Listed Sponsors
lead

Renovo

INDUSTRY

NCT00847795 - Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects. | Biotech Hunter | Biotech Hunter